MiniMed Flex is a smartphone-controlled insulin pump about half the size of MiniMed’s previous device. It’s the company’s ...
Medtronic is cutting its fourth quarter earnings guidance as it absorbs research and development costs for a new insulin pump ...
MiniMed is out to prove it deserves the name, with a new FDA clearance for its smallest insulin pump yet. | At about half ...
The timing of the initial public offering and the clearance of a new insulin pump are expected to affect Medtronic’s results ...
As Medtronic continues to await FDA clearance of the latest iteration of its MiniMed insulin pump, the medtech giant has churned out a steady stream of data supporting the device’s ability to improve ...
Medtronic (MDT) stock is in focus as the company cuts FY2026 EPS guidance to reflect recent updates involving its diabetes ...
MiniMed Flex™ is about half the size of the previous generation MiniMed™ 780G system, and features the SmartGuard™ adaptive ...
A new high-tech insulin pump that uses wireless technology to measure doses could be an important development in the treatment of diabetes and a boon to one of its creators, Northridge-based Medtronic ...
Medtronic reduces full-year earnings guidance following MiniMed Group IPO and one-time charge tied to Blackstone payments.
Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issue GALWAY, Ireland, Oct. 4 ...
Medtronic is recalling remote controllers used with its MiniMed 508 insulin pump and MiniMed Paradigm family of insulin pumps due to dangerous security flaws. The Food and Drug Administration on ...
The proposed IPO could see MiniMed offer 28m shares as the company looks to reach profitability independently of Medtronic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results